PAYER POLICY CHANGES

A9552 Insurance Policy Changes

HCPCS A9552 is officially defined as "Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries." HCPCS A9552 is referenced in 10 tracked payer policy changes from Excellus BlueCross BlueShield, Anthem BCBS, and 3 other payers. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS A9552 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Watch A9552

Get one email when a payer policy names A9552, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

See every payer rule for A9552

Prior authorization lists, coverage criteria, NCCI edits and Medicare coverage articles for A9552 in one place.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.